Reneural Technologies Secures £475K for Neurorehabilitation Growth
Reneural Technologies, previously known as CardioCrown, has made an impressive entry into the neurorehabilitation market as a Hatfield, UK-based provider. Recently, the company successfully raised £475K in PreSeed funding, a significant milestone that will aid its ambitious growth plans. This funding round was led by SFC Capital, with contributions from various undisclosed investors, and it coincided with Innovate UK's Investor Partnerships SME Round 7. Such financial backing not only underscores the potential of Reneural's innovative offerings but also highlights the growing interest in technologies that can provide meaningful support for stroke survivors.
Under the leadership of CEO Victor Harabari, Reneural Technologies is dedicated to addressing the pressing needs of individuals who have experienced strokes.
The company's comprehensive Neurorehabilitation platform uniquely integrates cutting-edge technologies such as virtual reality (VR), robotics, electromyography (EMG), and functional electrical stimulation (FES). This holistic approach aims to enhance patient outcomes significantly while also reducing healthcare costs. Moreover, by facilitating remote care, the platform alleviates some of the strain on healthcare professionals, allowing them to focus on delivering high-quality care where it's most needed.
Reneural's commitment to bridging the gap in continuous rehabilitation is evident through its comprehensive focus on a range of therapeutic areas. The platform is designed to address vital aspects of recovery, including physical rehabilitation, visual and cognitive improvement, and mental health therapies, all within a single, cohesive framework. This personalized approach to long-term care ensures that stroke survivors receive individualized support, enhancing their journey to recovery. With the potential to redefine the rehabilitation landscape, Reneural Technologies is poised to make a significant impact on the lives of many.
They've invested in Reneural Technologies
Get to know these Healthtech investors
Click here for a full list of 7,526+ startup investors in the UK